Retrospective analysis of the international standard-dose FOLFIRI (plus bevacizumab) regimen in Japanese patients with unresectable advanced or recurrent colorectal carcinoma
2011 ◽
Vol 16
(5)
◽
pp. 488-493
◽
2015 ◽
Vol 45
(8)
◽
pp. 774-779
◽
Keyword(s):
2017 ◽
Vol 18
(4)
◽
pp. e251-e258
◽
2013 ◽
Vol 2
(1)
◽
pp. 134-138
◽